← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sanguine Diagnostics And Therapeutics
Omaha, NE
$3,761,807
Total funding
5
Grants
Funding over time
peak $1.5M · FY2014–19$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,761,807 · 5
By mechanism
R44$3,011,807 · 2
R41$525,000 · 2
R43$225,000 · 1
Investigators at Sanguine Diagnostics And Therapeutics
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases$657,713
R44 · FY2018 · DK
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases$657,713
R44 · FY2019 · DK
Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer$650,357
R44 · FY2018 · CA
Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer$650,357
R44 · FY2019 · CA
Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and Prognosis$300,000
R41 · FY2016 · CA
Combinatorial Biomarkers for Malignant Polyps and Colon Cancer Detection$225,000
R43 · FY2019 · CA
Mucins in the Diagnosis and Prognosis of Pancreatic Diseases$225,000
R41 · FY2014 · CA
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases$199,020
R44 · FY2017 · DK
Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer$196,647
R44 · FY2018 · CA